MedTrace Logo

Evaluation of the Benefit and Tolerability of WAK2017 on Endothelial Function, Blood Pressure and Lipid Profile

NCT03287518 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-11-09

No results posted yet for this study

Summary

The main objective of the study is to evaluate the endothelial function of WAK2017. In addition the effects on the blood pressure and the parameters of lipid metabolism will be explored.

Conditions

  • Endothelial Function
  • Blood Pressure
  • Lipid Metabolism

Interventions

DIETARY_SUPPLEMENT

WAK2017

WAK2017 is a solution with following active ingredients: Aged Garlic Extract. One (1) ml IP should be taken with breakfast and one (1) ml with supper every day

DIETARY_SUPPLEMENT

Placebo

One (1) ml IP should be taken with breakfast and one (1) ml with supper every day

Sponsors & Collaborators

  • Analyze & Realize

    lead NETWORK

Principal Investigators

  • Ralf Uebelhack, MD · analyze & realize GmbH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-28
Primary Completion
2018-04-01
Completion
2018-09-15

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03287518 on ClinicalTrials.gov